Simvastatin exerts its anti-inflammatory effect in hypercholesterolaemic patients mainly by decreasing the serum levels of monocyte chemoattractant protein-1

被引：0
|
作者：
Rallidis, Loukianos
Hamodraka, Eftichia
Moustogiannis, Georgios
Fountoulaki, Katerina
Zolindaki, Maria
Kremastinos, Dimitrios
机构：
[1] Univ Gen Hosp, Athens, Greece
[2] Gen Hosp, Piraeus, Greece
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2007年 / 49卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：345A / 345A
页数：1
相关论文
共 50 条
  • [31] MYCOPHENOLIC ACID HAS ANTI-INFLAMMATORY CAPACITY BY INHIBITION OF MONOCYTE CHEMOATTRACTANT PROTEIN-1 PRODUCTION IN VASCULAR SMOOTH MUSCLE CELLS
    Schuchardt, M.
    Toelle, M.
    Pruefer, J.
    Huber, S.
    Zidek, W.
    van der Giet, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 84 - 84
  • [32] Gingival crevicular fluid levels of monocyte chemoattractant protein-1 in patients with aggressive periodontitis
    Gunpinar, S.
    Alptekin, N. O.
    Dundar, N.
    ORAL DISEASES, 2017, 23 (06) : 763 - 769
  • [33] MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1) LEVELS IN PATIENTS WITH GLOMERULAR-DISEASE
    ROVIN, BH
    DOE, N
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 851 - 851
  • [34] Anti-inflammatory effects of the monocyte chemoattractant protein-1 binding Spiegelmer® mNOX-E36 in two models of COPD
    Schwoebel, F.
    Eulberg, D.
    Purschke, W.
    Vonhoff, S.
    Humphrey, M.
    Morich, F.
    Klussmann, S.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2010, 381 : 39 - 39
  • [35] Monocyte chemoattractant protein 1 gene regulatory region polymorphism and serum levels of monocyte chemoattractant protein 1 in Japanese patients with Kawasaki disease
    Jibiki, T
    Terai, M
    Shima, M
    Ogawa, A
    Hamada, H
    Kanazawa, M
    Yamamoto, S
    Oana, S
    Kohno, Y
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : 2211 - 2212
  • [36] Correlation of plasma monocyte chemoattractant protein-1 (MCP-1) and monocyte inflammatory protein-1α (MIP-1α) levels with disease activity and clinical course of sarcoidosis
    Hashimoto, S
    Nakayama, T
    Gon, Y
    Hata, N
    Koura, T
    Maruoka, S
    Matsumoto, K
    Hayashi, S
    Abe, Y
    Horie, T
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1998, 111 (03): : 604 - 610
  • [37] Subcutaneous and continuous administration of lipopolysaccharide increases serum levels of triglyceride and monocyte chemoattractant protein-1 in rats
    Uchiumi, D
    Kobayashi, M
    Tachikawa, T
    Hasegawa, K
    JOURNAL OF PERIODONTAL RESEARCH, 2004, 39 (02) : 120 - 128
  • [38] Progression of Type 2 Diabetic Nephropathy and Serum Monocyte Chemoattractant Protein-1 (MCP-1) Levels
    Mohammed, Ahmed S.
    Al-Saeed, Hassan H.
    Malik, Arif Sami
    Alhassnawi, Muqdam Ali
    Khlaif, Mohammed S.
    Qassim, Ali Abdulla
    RESEARCH JOURNAL OF BIOTECHNOLOGY, 2023, 18 (09): : 132 - 136
  • [39] Altered serum transforming growth factor-β1 and monocyte chemoattractant protein-1 levels in obstructive jaundice
    Sheen-Chen, SM
    Eng, HL
    Hung, KS
    WORLD JOURNAL OF SURGERY, 2004, 28 (10) : 967 - 970
  • [40] Altered Serum Transforming Growth Factor-ß1 and Monocyte Chemoattractant Protein-1 Levels in Obstructive Jaundice
    Shyr-Ming Sheen-Chen
    Hock-Liew Eng
    Kuo-Sheng Hung
    World Journal of Surgery, 2004, 28 : 967 - 970
12345